SlideShare une entreprise Scribd logo
1  sur  112
www.Examville.com Online practice tests, live classes, tutoring, study guides Q&A, premium content and more .
Cardiac Medications
Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Inotropes
Inotropes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class Participation Question #1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class Participation Question #1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cardiac Glycosides  ,[object Object]
Digoxin MOA
Digoxin (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class Participation Question 2: ,[object Object]
Class Participation Question 2: ,[object Object],[object Object],[object Object]
Class Participation Question 2: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class Participation Question 2: ,[object Object],[object Object],[object Object]
Latest News on Digoxin ,[object Object],[object Object]
Digitalis Toxicity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Chronotropes
Chronotropes ,[object Object],[object Object],[object Object]
Chronotropes (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Positive Chronotrope ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Atropine (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Atropine Dosing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Anti-anginal Drugs
Antianginal Drugs ,[object Object],[object Object],[object Object]
Symptoms of Angina
Nitrites/Nitrates ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class Participation Question #3: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class Participation Question #3: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drug (Trade Name) Common Dosage Onset Duration Amyl nitrate (Vaporole ® ) 0.3 ml inhalation 30-60 sec 10 min ISDN (Isordil ® ) 2.5 - 10 mg SL 5 - 30 mg po qid 2-5 min 2 - 4 hr Nitroglycerin ( Nitro-bid ® ) 2% ointment 15 min 4 - 8 hr ( Nitrostat ® ) 0.3 - 0.6 mg   SL 1-3 min 10 - 45 min ( Nitrogard ® ) 1,2,3 mg XR tab 30 min 8 - 12 hr ( Transderm-Nitro ® ) 2.5 - 15 mg/day Transdermal patch 30-60 min 24 hr
 
Nitroglycerin (NG)  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
NG (cont’d) ,[object Object],[object Object],[object Object],[object Object]
NG (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Antidysrhythmics/Antiarrhythmics
What are Arrhythmias? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Antidysrhythmics/Antiarrhythmics ,[object Object],[object Object],[object Object]
Antidysrhythmics/Antiarrhythmics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cardiac Action Potential ,[object Object],[object Object],[object Object],[object Object],[object Object]
Class Participation Question #4: ,[object Object],[object Object]
Class Participation Question #4: ,[object Object],[object Object],[object Object]
The Catch 22 with Antiarrhythmics ,[object Object],[object Object],[object Object]
Antiarrthymics: Class I ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class I A ,[object Object],[object Object],[object Object]
Class 1A – Quinidine  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class 1A – Quinidine (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class I B ,[object Object],[object Object],[object Object],[object Object]
Lidocaine – Class IB ,[object Object],[object Object],[object Object]
Dosage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Lidocaine – Class IB (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Lidocaine (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class I C ,[object Object],[object Object]
Flecainide – Class IC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Flecainide – Class IC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class II – Beta Blockers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Propranolol Warning ,[object Object],[object Object],[object Object],[object Object]
Class III ,[object Object],[object Object],[object Object],[object Object],[object Object]
Amiodarone – Class III ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Vfib Amiodarone Dosage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Amiodarone – Adverse Reactions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Amiodarone – Class III (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Class IV ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sympathomimetics
Sympathomimetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Epinephrine  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Epinephrine MOA
Epinephrine (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Epinephrine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Vasopressors
Vasopressors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Vasoconstrictor ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Vasopressin ,[object Object],[object Object],[object Object],[object Object]
Vasopressin (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Vasopressin (cont’d) ,[object Object],[object Object],[object Object],[object Object]
Vasopressin (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diuretics
Diuretics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Diuretic Properties Diuretic agent Site of Action & Misc.  Chlorothiazide PO/IV Distal Tubule   Calcium Reabsorption Increased  May transiently increase Lipids, BG and UA  Hypomagnesemia (may complicate K+ correction) Severe Potassium Depletion – Creation of Combos ??? Pregnancy categories: B and C Hydrochlorothiazide  Indapamide  Metolazone (Mykrox) Furosemide Ascending Limb of Henle Ototoxocity (reversible and irreversible)  Hypokalemia (supplement with K+)  Pregnancy categories: B  Torsemide Bumetanide Ethacrynic acid Amiloride  Distal and Proximal tubule Impact   Hyperkalemia and serum creatinine elevations Avoidance: BUN > 30 mg/dl or SCr > 1.5 mg/dl Triamterene  Eplerenone Distal and Aldosterone receptor Impact Same as amiloride and triamterene – avoid K spare combos Spironolactone
Diuretics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Furosemide – Edema Dosage ,[object Object],[object Object]
Furosemide ,[object Object],[object Object],[object Object]
Furosemide (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Anticoagulants
Antiplatelets/Anticoagulants ,[object Object],[object Object],[object Object]
Types of Antiplatelets/Anticoagulants ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Antiplatelets/Anticoagulants ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Heparin Recall in 2008 ,[object Object]
Coagulation Cascade
Warfarin – Oral Anticoagulant ,[object Object]
Warfarin (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Warfarin Warnings ,[object Object],[object Object],[object Object]
Warfarin (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object]
Fibrinolytic Enzymes
Fibrinolytic Enzymes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Streptokinase (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Streptokinase (cont’d) ,[object Object],[object Object],[object Object],[object Object]
Streptokinase (cont’d)
Beta Blockers
Beta Blockers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Beta Blockers (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Propranolol ,[object Object],[object Object],[object Object],[object Object],[object Object]
Propranolol (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Propranolol (cont’d) ,[object Object],[object Object],[object Object]
Calcium Channel Blockers
Calcium Channel Blockers (CCBs) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CCBs (cont’d) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Amlodipine ,[object Object],[object Object],[object Object],[object Object],[object Object]
Amlodipine http://online.factsandcomparisons.com/MonoDisp.aspx?monoID=fandc-hcp10122&inProdGen=true&quick=Amlodipine&search=Amlodipine
Amlodipine ,[object Object],[object Object],[object Object],[object Object]
It’s FREE to join. http://www.examville.com

Contenu connexe

Tendances

Inotropes & Vasopressors
Inotropes & Vasopressors Inotropes & Vasopressors
Inotropes & Vasopressors Sphurthy Gattu
 
Inotropes and vasopressors in cardiogenic shock
Inotropes and vasopressors in cardiogenic shockInotropes and vasopressors in cardiogenic shock
Inotropes and vasopressors in cardiogenic shockAnwar Yusr
 
Anti htn medication.pptx maqsood
Anti htn medication.pptx maqsoodAnti htn medication.pptx maqsood
Anti htn medication.pptx maqsoodMohd Maqsood
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergenciesPrasenjit Gogoi
 
Updates on blood transfusion
Updates on blood transfusion Updates on blood transfusion
Updates on blood transfusion Anwar Yusr
 
Hypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and EmergenciesHypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and Emergenciessazzad92
 
hypertension treatment update
hypertension treatment updatehypertension treatment update
hypertension treatment updateBasem Enany
 
Hypertensive emergencies management
Hypertensive emergencies managementHypertensive emergencies management
Hypertensive emergencies managementDR VISHNU RS
 
hypertension emergencies
hypertension emergencieshypertension emergencies
hypertension emergenciesaws aliraqi
 
Debbie's Cardiac Meds Presentation Final Nn
Debbie's Cardiac Meds Presentation Final NnDebbie's Cardiac Meds Presentation Final Nn
Debbie's Cardiac Meds Presentation Final Nnguestf41297
 
Rational choice of inotropes and vasopressors in intensive care unit
Rational choice of inotropes and vasopressors in intensive care unitRational choice of inotropes and vasopressors in intensive care unit
Rational choice of inotropes and vasopressors in intensive care unitSaneesh P J
 
Hypensive urgency and emergency
Hypensive urgency and emergencyHypensive urgency and emergency
Hypensive urgency and emergencyJESSE OWAKI
 
Cardiogenic Shock And Arrhythmias
Cardiogenic Shock And ArrhythmiasCardiogenic Shock And Arrhythmias
Cardiogenic Shock And ArrhythmiasAndrew Ferguson
 
acute heart failure:therapeutic update
acute heart failure:therapeutic updateacute heart failure:therapeutic update
acute heart failure:therapeutic updatemagdy elmasry
 
Case on Ischemic Stroke
Case on Ischemic StrokeCase on Ischemic Stroke
Case on Ischemic StrokeSUNIL NAYAK
 

Tendances (20)

Inotropes & Vasopressors
Inotropes & Vasopressors Inotropes & Vasopressors
Inotropes & Vasopressors
 
Cardic emergency
Cardic emergencyCardic emergency
Cardic emergency
 
Inotropes and vasopressors in cardiogenic shock
Inotropes and vasopressors in cardiogenic shockInotropes and vasopressors in cardiogenic shock
Inotropes and vasopressors in cardiogenic shock
 
Anti htn medication.pptx maqsood
Anti htn medication.pptx maqsoodAnti htn medication.pptx maqsood
Anti htn medication.pptx maqsood
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
 
Updates on blood transfusion
Updates on blood transfusion Updates on blood transfusion
Updates on blood transfusion
 
Hypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and EmergenciesHypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and Emergencies
 
hypertension treatment update
hypertension treatment updatehypertension treatment update
hypertension treatment update
 
Critical Medications
Critical MedicationsCritical Medications
Critical Medications
 
Hypertensive emergencies management
Hypertensive emergencies managementHypertensive emergencies management
Hypertensive emergencies management
 
hypertension emergencies
hypertension emergencieshypertension emergencies
hypertension emergencies
 
Debbie's Cardiac Meds Presentation Final Nn
Debbie's Cardiac Meds Presentation Final NnDebbie's Cardiac Meds Presentation Final Nn
Debbie's Cardiac Meds Presentation Final Nn
 
Rational choice of inotropes and vasopressors in intensive care unit
Rational choice of inotropes and vasopressors in intensive care unitRational choice of inotropes and vasopressors in intensive care unit
Rational choice of inotropes and vasopressors in intensive care unit
 
Hypensive urgency and emergency
Hypensive urgency and emergencyHypensive urgency and emergency
Hypensive urgency and emergency
 
Cardiogenic shock 1
Cardiogenic shock 1Cardiogenic shock 1
Cardiogenic shock 1
 
Hypertensive emgerencies
Hypertensive emgerenciesHypertensive emgerencies
Hypertensive emgerencies
 
Cardiogenic Shock And Arrhythmias
Cardiogenic Shock And ArrhythmiasCardiogenic Shock And Arrhythmias
Cardiogenic Shock And Arrhythmias
 
acute heart failure:therapeutic update
acute heart failure:therapeutic updateacute heart failure:therapeutic update
acute heart failure:therapeutic update
 
ACE inhibitors drugs
ACE inhibitors drugsACE inhibitors drugs
ACE inhibitors drugs
 
Case on Ischemic Stroke
Case on Ischemic StrokeCase on Ischemic Stroke
Case on Ischemic Stroke
 

Similaire à Cardiac Medications

Cardiac medications
Cardiac medicationsCardiac medications
Cardiac medicationsJSlinkyNY
 
3,4- Anti-arrhythmic drugs.pptx
3,4- Anti-arrhythmic drugs.pptx3,4- Anti-arrhythmic drugs.pptx
3,4- Anti-arrhythmic drugs.pptxTatjanaMii3
 
Pharmacology of Antidysrhythmic and Vasoactive Medications
Pharmacology of Antidysrhythmic and Vasoactive MedicationsPharmacology of Antidysrhythmic and Vasoactive Medications
Pharmacology of Antidysrhythmic and Vasoactive Medicationsshabeel pn
 
Pharmacology positive-positive inotropicagentsfixed
Pharmacology positive-positive inotropicagentsfixedPharmacology positive-positive inotropicagentsfixed
Pharmacology positive-positive inotropicagentsfixedpytos08
 
Cardiac medications
Cardiac medicationsCardiac medications
Cardiac medicationsjjones51
 
Emergency drug list
Emergency drug listEmergency drug list
Emergency drug listLucky Khan
 
Antiarrhythmicdrug therapy Dr Vinay Verma
Antiarrhythmicdrug therapy       Dr Vinay Verma Antiarrhythmicdrug therapy       Dr Vinay Verma
Antiarrhythmicdrug therapy Dr Vinay Verma Dr Harikrishna Harindran
 
Effect of drugs on frog’s heart
Effect of drugs on frog’s heart Effect of drugs on frog’s heart
Effect of drugs on frog’s heart Karun Kumar
 
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of PharmacyAntiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of PharmacyIlangovan Ponnilavarasan
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoningRiddhi Pawaskar
 
160465212 case-study-new-03
160465212 case-study-new-03160465212 case-study-new-03
160465212 case-study-new-03homeworkping7
 
Pharm Exam Study Guide 1 & 2 Presentation1
Pharm Exam Study Guide 1 & 2 Presentation1Pharm Exam Study Guide 1 & 2 Presentation1
Pharm Exam Study Guide 1 & 2 Presentation1Carrie Wyatt
 

Similaire à Cardiac Medications (20)

Cardiac medications
Cardiac medicationsCardiac medications
Cardiac medications
 
3,4- Anti-arrhythmic drugs.pptx
3,4- Anti-arrhythmic drugs.pptx3,4- Anti-arrhythmic drugs.pptx
3,4- Anti-arrhythmic drugs.pptx
 
Pharmacology of Antidysrhythmic and Vasoactive Medications
Pharmacology of Antidysrhythmic and Vasoactive MedicationsPharmacology of Antidysrhythmic and Vasoactive Medications
Pharmacology of Antidysrhythmic and Vasoactive Medications
 
Pharmacology positive-positive inotropicagentsfixed
Pharmacology positive-positive inotropicagentsfixedPharmacology positive-positive inotropicagentsfixed
Pharmacology positive-positive inotropicagentsfixed
 
Cardiac medications
Cardiac medicationsCardiac medications
Cardiac medications
 
Emergency drug list
Emergency drug listEmergency drug list
Emergency drug list
 
anti-arrhythmics
anti-arrhythmicsanti-arrhythmics
anti-arrhythmics
 
Antiarrhythmicdrug therapy Dr Vinay Verma
Antiarrhythmicdrug therapy       Dr Vinay Verma Antiarrhythmicdrug therapy       Dr Vinay Verma
Antiarrhythmicdrug therapy Dr Vinay Verma
 
Cardiovascular Drugs
Cardiovascular Drugs Cardiovascular Drugs
Cardiovascular Drugs
 
Effect of drugs on frog’s heart
Effect of drugs on frog’s heart Effect of drugs on frog’s heart
Effect of drugs on frog’s heart
 
Inotropesfs
InotropesfsInotropesfs
Inotropesfs
 
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of PharmacyAntiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
SHOCK
SHOCKSHOCK
SHOCK
 
Inotropes
InotropesInotropes
Inotropes
 
3arrythmia pharmacotherapy
3arrythmia pharmacotherapy3arrythmia pharmacotherapy
3arrythmia pharmacotherapy
 
Beta blockers
Beta blockers Beta blockers
Beta blockers
 
Rsi
RsiRsi
Rsi
 
160465212 case-study-new-03
160465212 case-study-new-03160465212 case-study-new-03
160465212 case-study-new-03
 
Pharm Exam Study Guide 1 & 2 Presentation1
Pharm Exam Study Guide 1 & 2 Presentation1Pharm Exam Study Guide 1 & 2 Presentation1
Pharm Exam Study Guide 1 & 2 Presentation1
 

Plus de Examville.com LLC (20)

Top 10 Things You Can Do at Examville
Top 10 Things You Can Do at ExamvilleTop 10 Things You Can Do at Examville
Top 10 Things You Can Do at Examville
 
How to prepare for the gmat
How to prepare for the gmatHow to prepare for the gmat
How to prepare for the gmat
 
Top universities in the world
Top universities in the worldTop universities in the world
Top universities in the world
 
HIV - A Summary Review
HIV - A Summary ReviewHIV - A Summary Review
HIV - A Summary Review
 
Chest Heart and Lungs
Chest Heart and LungsChest Heart and Lungs
Chest Heart and Lungs
 
Human Heart
Human HeartHuman Heart
Human Heart
 
Mediastinum
MediastinumMediastinum
Mediastinum
 
Pericardium
PericardiumPericardium
Pericardium
 
Respiratory System
Respiratory SystemRespiratory System
Respiratory System
 
Collagen
CollagenCollagen
Collagen
 
Bioenergetics
BioenergeticsBioenergetics
Bioenergetics
 
Abdomen
AbdomenAbdomen
Abdomen
 
Lipids
LipidsLipids
Lipids
 
The Pancreas
The PancreasThe Pancreas
The Pancreas
 
The Head - Human Anatomy
The Head - Human AnatomyThe Head - Human Anatomy
The Head - Human Anatomy
 
Male Reproductive System
Male Reproductive SystemMale Reproductive System
Male Reproductive System
 
GMAT GRE SAT M
GMAT GRE SAT MGMAT GRE SAT M
GMAT GRE SAT M
 
Proteins, Amino Acids and Peptides - A Review
Proteins, Amino Acids and Peptides - A ReviewProteins, Amino Acids and Peptides - A Review
Proteins, Amino Acids and Peptides - A Review
 
Shoulder and Pectoral Girdle
Shoulder and Pectoral GirdleShoulder and Pectoral Girdle
Shoulder and Pectoral Girdle
 
The Cardiovascular System
The Cardiovascular SystemThe Cardiovascular System
The Cardiovascular System
 

Dernier

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 

Dernier (20)

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 

Cardiac Medications

Notes de l'éditeur

  1. suppress fast rhythms of the heart ( cardiac arrhythmias ), such as atrial fibrillation , atrial flutter , ventricular tachycardia , and ventricular fibrillation . It is important to stress that these medications do NOT cure the underlying cause of an arrhythmia Normal: depending on your age and physical conditioning 60-80 bpm Tachcarydia: 150-250 bpm Bradycardia: < 60 bpm Irregular heart beat due to extra beats or fibrillation
  2. Antiarrhythmic drugs are grouped into 4 classes using the Vaughan Williams classification , introduced in 1970 Drugs are classfied based on its primary mechanism of its antiarrhythmic effect. However, one of the limitations of the VW classifcations, is that many antiarrhtmic agenst have MULTIPLE MOAs Arrythmias, hypertension, heart failure or myocardial infarctions
  3. sodium, and magnesium levels. Low potassium and magnesium levels can lead to heart rhythm abnormalities, especially in patients already taking digoxin (Lanoxin). Please visit the digoxin (Lanoxin) site for further information.
  4. .